logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Galectins And Disease Implications For Targeted Therapeutics Anatole A Klyosov And Peter G Traber Eds

  • SKU: BELL-4338180
Galectins And Disease Implications For Targeted Therapeutics Anatole A Klyosov And Peter G Traber Eds
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Galectins And Disease Implications For Targeted Therapeutics Anatole A Klyosov And Peter G Traber Eds instant download after payment.

Publisher: American Chemical Society
File Extension: PDF
File size: 11.16 MB
Pages: 425
Author: Anatole A. Klyosov and Peter G. Traber (Eds.)
ISBN: 9780841228801, 9780841228818, 0841228809, 0841228817
Language: English
Year: 2012

Product desciption

Galectins And Disease Implications For Targeted Therapeutics Anatole A Klyosov And Peter G Traber Eds by Anatole A. Klyosov And Peter G. Traber (eds.) 9780841228801, 9780841228818, 0841228809, 0841228817 instant download after payment.

Content: CONTENTS ; PREFACE ; OVERVIEW ; 1. GALECTINS IN DISEASE AND POTENTIAL THERAPEUTIC APPROACHES ; ANATOLE A. KLYOSOV AND PETER G. TRABER ; GALECTIN AND GALECTIN INHIBITORS: STRUCTURAL ASPECTS ; 2. LOW-MOLECULAR WEIGHT INHIBITORS OF GALECTINS ; HAKON LEFFLER AND ULF J. NILSSON ; 3. FROM CARBOHYDRATE TO PEPTIDOMIMETIC INHIBITORS OF GALECTINS ; KEVIN H. MAYO ; GALECTIN EXTRA- AND INTRA-CELLULAR FUNCTIONS AND ; THEIR THERAPEUTIC IMPLICATIONS ; 4. INTRACELLULAR GALECTINS: PLATFORMS FOR ASSEMBLY OF MACROMOLECULAR ; COMPLEXES ; JOHN L. WANG, KEVIN C. HAUDEK, PATRICIA G. VOSS, RONALD J. PATTERSON, AND ; ERIC J. ARNOYS ; 5. GALECTINS AS NOVEL REGULATORS OF PLATELET SIGNALING AND FUNCTION: ; THERAPEUTIC IMPLICATIONS ; GABRIEL A. RABINOVICH AND MIRTA SCHATTNER ; 6. GALECTIN-1 CROSS-LINKING OF GM1 GANGLIOSIDE IN AUTOIMMUNE ; SUPPRESSION ; ROBERT W. LEDEEN, GUSHENG WU, DAVID BLEICH, ZI-HUA LU, AND HANS-JOACHIM GABIUS ; 7. HOW TO BUILD "LEAN AND MEAN" ANTI-TUMOR T CELLS: A STRATEGIC VIEW INTO ; THE ANTI-CARBOHYDRATE ACTION OF FLUORINATED GLUCOSAMINE ANALOGS ; CHARLES J. DIMITROFF ; 8. POST-TRANSLATIONAL MODIFICATION OF GALECTIN-3 AND ITS ROLE IN BIOLOGICAL ; FUNCTION ; JAMES C. BYRD, NACHMAN MAZUREK, AND ROBERT S. BRESALIER ; GALECTIN MECHANISMS AND THERAPEUTIC APPROACHES IN CANCER ; 9. THE ROLE OF GALECTIN-3 IN MALIGNANT MELANOMA ; GORDANA RADOSAVLJEVIC, IVAN JOVANOVIC, JELENA PANTIC, NADA PEJNOVIC, ; NEBOJSA ARSENIJEVIC, DANIEL K. HSU, AND MIODRAG L. LUKIC ; 10. GALECTINS AS NOVEL TARGETS FOR THE TREATMENT OF MALIGNANT GLIOMAS ; HERWIG M. STRIK AND MATTHIAS OCKER ; 11. DYNAMIC TUNING OF GALECTINS AND THEIR BINDING SITES DURING MAMMARY ; TUMOR PROGRESSION AND METASTASIS ; JOANA T. DE OLIVEIRA AND FATIMA GARTNER ; 12. GALECTIN-3C: HUMAN LECTIN FOR TREATMENT OF CANCER ; GARY A. JARVIS, LEONARDO MIRANDOLA, YU YUEFEI, EVERARDO COBOS, ; MAURIZIO CHIRIVA-INTERNATI, AND CONSTANCE M. JOHN ; 13. ANGIOSTATIC CANCER THERAPY BY TARGETING GALECTINS IN THE TUMOR ; VASCULATURE ; IRIS A. SCHULKENS, ARJAN W. GRIFFIOEN, AND VICTOR L. THIJSSEN ; 14. GALECTINS AND PATHOLOGIES: ROLE OF GALECTIN-3 IN THE COMMUNICATION ; BETWEEN LEUKEMIA CELLS AND THE MICROENVIRONMENT ; NORA HEISTERKAMP, FEI FEI, AND JOHN GROFFEN ; 15. TRANSLATIONAL RATIONAL FOR THE CLINICAL DEVELOPMENT OF OTX-008: A NOVEL ; DRUG THAT INHIBITS GALECTIN-1 EXPRESSION IN HUMAN CANCER MODELS ; ERIC RAYMOND, LUCILE ASTRORGUE-XERRI, MARIA SEROVA, MARIA EUGENIA RIVEIRO, AND ; SANDRINE FAIVRE ; 16. IMPROVING THE CLINICAL EFFICACY OF CANCER VACCINES BY TARGETING IMMUNE ; SUPPRESSION IN HUMAN TUMORS ; NATHALIE DEMOTTE, ARISTOTELIS ANTONOPOULOS, JEAN-FRANCOIS BAURAIN, GREGOIRE WIEERS, ; NICOLAS VAN BAREN, AND PIERRE VAN DER BRUGGEN ; 17. TARGETING GALECTIN-3 UNVEILS THE COMPLEXITY OF MULTIPLE MYELOMA: A ; SWEET CONTEXT ; LEONARDO MIRANDOLA, YUEFEI YU, CONSTANCE M. JOHN, MARJORIE JENKINS, ; EVERARDO COBOS, AND MAURIZIO CHIRIVA-INTERNATI ; 18. GALECTINS IN THE BLOOD CIRCULATION: POTENTIAL THERAPEUTIC TARGETS OF ; CANCER METASTASIS ; CARRIE A. DUCKWORTH AND LU-GANG YU ; GALECTIN MECHANISMS AND THERAPEUTIC APPROACHES IN ; INFLAMMATION AND FIBROSIS ; 19. A THERAPEUTIC ROLE FOR GALECTINS IN ACUTE INFLAMMATION? ; DIANNE COOPER ; 20. GALECTINS IN IMMUNE AND INFLAMMATORY DISEASES: INSIGHTS FROM ; EXPERIMENTS WITH GALECTIN DEFICIENT MICE ; DANIEL K. HSU, RI-YAO YANG, AGNES FERMIN, AND FU-TONG LIU ; 21. AUTOIMMUNE DISORDERS IN GALECTIN-3 DEFICIENT MICE ; VLADISLAV VOLAREVIC AND MIODRAG L. LUKIC ; 22. GALECTIN-3: A CENTRAL REGULATOR OF CHRONIC INFLAMMATION AND TISSUE ; FIBROSIS ; NEIL C. HENDERSON, ALISON C. MACKINNON, CLAIRE ROONEY, AND TARIQ SETHI ; 23. THE ROLE OF GALECTIN-3 IN STELLATE CELL ACTIVATION AND LIVER FIBROSIS ; JOY X. JIANG, XIANGLING CHEN, HIROO FUKADA, DAN K. HSU, FU-TONG LIU, AND ; NATALIE J. TOROK ; 24. GALECTIN-3 MEDIATED CARDIOVASCULAR FIBROGENESIS: AN IMPORTANT CAUSE OF ; HEART FAILURE AND CARDIOVASCULAR MORTALITY ; WOUTER C. MEIJERS AND RUDOLF A. DE BOER ; 25. MUCINS AND GALECTIN-3 IN OCULAR SURFACE HEALTH AND DISEASE ; JEROME MAURIS AND PABLO ARGUESO ; 26. ROLE OF GALECTINS IN WOUND HEALING ; NOORJAHAN PANJWANI, PH.D. ; EDITORS' BIOGRAPHIES ; INDEXES ; AUTHOR INDEX ; SUBJECT INDEX

Related Products